UPDATE: Raymond James Downgrades Antares Pharma (ATRS) to Market Perform
Tweet Send to a Friend
(Updated - April 14, 2022 5:54 AM EDT)
Raymond James analyst Elliot Wilbur downgraded Antares Pharma (NASDAQ: ATRS) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Raymond James analyst Elliot Wilbur downgraded Antares Pharma (NASDAQ: ATRS) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
